1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Walker & Dunlop's operating subsidiary signed Amendment No. 4 to a side letter with JPMorgan Chase Bank, N.A., revising the Uncommitted Facility Amount under an existing master repurchase agreement. The uncommitted limit rises temporarily to $1.45 billion from August 26, 2025 through November 20, 2025, then reverts to $950 million, giving the company more short-term borrowing capacity with its lender.
Amendment dated August 26, 2025 between Walker & Dunlop, LLC and JPMorgan Chase Bank, N.A.
Uncommitted Facility Amount temporarily increases to $1.45 billion through November 20, 2025
Amount reverts to $950 million after November 20, 2025
Filing notes JPMorgan also provides other financial services, including another credit facility and investment banking
Sarepta Therapeutics exchanged $700.0 million of its 1.25% convertible notes due 2027 for $602.0 million of new 4.875% convertible notes due 2030, 5,851,693 shares of common stock and about $123.3 million in cash. The new notes were issued August 28, 2025, and the company also sold 1,106,806 shares to J. Wood Capital Advisors LLC at $18.07 per share, so shareholders face a new debt obligation alongside potential dilution from share issuance and conversion.
Exchanged $700.0 million of 1.25% notes due 2027 for $602.0 million of new 4.875% notes due September 1, 2030, plus 5,851,693 shares and about $123.3 million in cash
New notes have an initial conversion price of about $60.00 per share, versus $20.58 last reported sale price on August 20, 2025
Interest is payable March 1 and September 1 each year, beginning March 1, 2026
Concurrent private placement of 1,106,806 shares to J. Wood Capital Advisors LLC at $18.07 per share
McKinley Acquisition Corporation filed an 8-K to report that it completed its initial public offering of 15,000,000 units at $10.00 per unit, generating $150 million in gross proceeds, plus a private placement of 465,000 units. The $150 million was deposited in a trust account for public shareholders, and the auditor's report includes a going concern warning, stating that the company lacks the capital to fund operations for a reasonable period and that there is substantial doubt about its ability to continue. The company has not yet identified a business combination target and must complete one within 18 months of the IPO closing or redeem public shares.
15,000,000 units sold at $10.00 each, generating $150 million in gross proceeds; the IPO closed on August 13, 2025
465,000 private placement units sold at $10.00 each, or $4.65 million, to McKinley Partners LLC, Clear Street LLC and Brookline Capital Markets, with $500,000 not yet received
$150 million deposited in the trust account for public shareholders as of August 13, 2025; the company has 18 months to complete an initial business combination
CBIZ CPAs P.C. included a going concern explanatory paragraph in its audit report dated August 29, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.